@tech.eu 1 year ago
Amadeus Capital Partners’ Volker Hirsch joins Medicines Discovery Catapult as Chief Commercial Officer
@Cambridge_Uni 3 years ago
Join the Cambridge Centre for AI in Medicine @CC4AIM on Friday 22 January to find out how #AI and #machinelearning are transforming medicine and bioscience. Tickets are free – find out more https://bit.ly/3if4Mr0 https://t.co/VBIQzZTRzi
@businessweekly 3 years ago
AstraZeneca and GSK back new Cambridge centre for #AI in medicine https://bit.ly/3ljUXZI The University of Cambridge has unveiled a five-year agreement with @AstraZeneca and @GSK to fund the Cambridge Centre for AI in Medicine – @CC4AIM #machinelearning https://t.co/ZasK9DaFtW
@CC4AIM 3 years ago
We are delighted to announce the official launch of the Cambridge Centre for AI in Medicine. Find out more about our vision for transforming healthcare and our partnership with AstraZeneca and GSK https://bit.ly/CCAIM-launch #AI #machinelearning #healthtech https://t.co/3l1w3O5jdm
@Cambridge_Uni 3 years ago
The pandemic has presented huge challenges for #clinicaltrials, but #machinelearning techniques could help improve them, both during the pandemic and beyond. New research from the Cambridge Centre for AI in Medicine @CC4AIM: https://bit.ly/3hX7gIT @MihaelaVDS #COVID19
@AdaptCentre 4 years ago
ADAPT Centre, @tcddublin, Tallaght University Hospital, and Trinity Translational Medicine Institute awarded €2.3M for the FAIRVASC project on #vasculitis research. Professors Mark Little and Declan O’Sullivan are Key Principal Investigators. #BigData https://www.adaptcentre.ie/news/2.3m-award-for-advanced-data-linkage-technologies-to-study-rare-disease https://t.co/TzoJ1jPDIl